FDA Approved: PONVORY — Supplemental Application (Janssen Pharmaceuticals, Inc)

View source ↗

Summary

FDA approved Janssen's supplemental application for PONVORY (ponesimod), authorizing changes to its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• PONVORY (PONESIMOD)

Snippet

SUPPL AP for PONVORY (PONESIMOD)